Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
abiraterone (zytiga) (2 trials)
methylprednisolone (medrol) (1 trial)
ags-003 (1 trial)
carboplatin (paraplatin) (1 trial)
cisplatin (platinol) (1 trial)
degarelix acetate (firmagon) (1 trial)
paclitaxel (taxol) (1 trial)
pemetrexed (alimta) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Prostatic Neoplasms (Phase 3)
Trials (3 total)
Trial APIs (8 total)